Marcelo Vier Gambetta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marcelo Vier Gambetta has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Oliveira Fischer Bacca
University Center for the Development of Alto Vale - UNIDAVI, Medical Sciences Research Center, Rio do Sul, Brazil
5 shared publications - Franciani Rodrigues da Rocha
Núcleo de Pesquisa em Ciências Médicas: investigações em saúde -NPCMed, Faculdade de Medicina, Centro Universitário para o Desenvolvimento do Alto Vale do Itajaí -UNIDAVI, Jardim América, Rio do Sul, Santa Catarina, 89160-932, Brasil
4 shared publications - Nicolas Ramos
Centro Universitário para o Desenvolvimento de Alto Vale, Rio do Sul, SC, Brazil
3 shared publications - Ana Luiza Nardelli Kuhl
Núcleo de Pesquisa em Ciências Médicas
2 shared publications - Luiz Fernando Matias
Núcleo de Pesquisa em Ciências Médicas
2 shared publications - Silvia Rozauria Froes Toniazzo
Centro Universitário para o Desenvolvimento do Alto Vale do Itajaí (UNIDAVI)
2 shared publications
Latest Publications
- 14 March 2026
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 28 (3) , 473-483
Finerenone, eplerenone, and spironolactone in heart failure with preserved ejection fraction: a Bayesian network meta-analysis of efficacy and safety
Aims: The comparative effects of mineralocorticoid receptor antagonists (MRAs) in heart failure with preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF) remain uncertain, including potential differences between steroidal MRAs and finerenone. This Bayesian network meta-analysis aimed to compare the efficacy and safety of finerenone, eplerenone, and spironolactone vs placebo in HFpEF/HFmrEF. Methods: We searched Pubmed, Cochrane, and Embase for studies focused on MRA treatment in HFpEF and/or HFmrEF. Eight randomized controlled trials enrolling adults with HFpEF or HFmrEF (LVEF ≥40%) were analysed in a fixed-effects Bayesian network meta-analysis. Risk ratios (RRs) with 95% credible intervals (CrIs) were estimated for hospitalization for HF, cardiovascular death, and hyperkalaemia. Heterogeneity was assessed using I2. Results: Across a network comprising 10 644 patients, mean age 70.2; 48% women; mean LVEF 54.9%, finerenone reduced hospitalization for HF vs placebo (RR 0.84; 95% CrI 0.75–0.93), whereas spironolactone (RR 0.86; 95% CrI 0.73–1.01) and eplerenone (RR 0.86; 95% CrI 0.59–1.26) showed non-significant effects. None of the MRAs achieved a statistically significant reduction in cardiovascular mortality vs placebo: finerenone (RR 0.93; 95% CrI 0.78–1.10), spironolactone (RR 0.93; 95% CrI 0.76–1.14), and eplerenone (RR 1.10; 95% CrI 0.29–5.69). All MRAs increased hyperkalaemia vs placebo: finerenone (RR 2.06; 95% CrI 1.77–2.41), spironolactone (RR 2.13; 95% CrI 1.81–2.53), and eplerenone (RR 2.17; 95% CrI 0.75–7.97). Conclusion: In HFpEF/HFmrEF, finerenone was the only MRA to significantly reduce hospitalization for HF, while no agent significantly reduced cardiovascular mortality and hyperkalaemia risk increased across therapies. Overall, finerenone may offer the most favourable efficacy–safety balance among MRAs, pending confirmation in larger dedicated trials.
- 14 March 2026
- Published by Oxford University Press (OUP) in European Journal of Heart Failure
- Vol. 28 (3) , 473-483
Finerenone, eplerenone, and spironolactone in heart failure with preserved ejection fraction: a Bayesian network meta-analysis of efficacy and safety
Aims: The comparative effects of mineralocorticoid receptor antagonists (MRAs) in heart failure with preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF) remain uncertain, including potential differences between steroidal MRAs and finerenone. This Bayesian network meta-analysis aimed to compare the efficacy and safety of finerenone, eplerenone, and spironolactone vs placebo in HFpEF/HFmrEF. Methods: We searched Pubmed, Cochrane, and Embase for studies focused on MRA treatment in HFpEF and/or HFmrEF. Eight randomized controlled trials enrolling adults with HFpEF or HFmrEF (LVEF ≥40%) were analysed in a fixed-effects Bayesian network meta-analysis. Risk ratios (RRs) with 95% credible intervals (CrIs) were estimated for hospitalization for HF, cardiovascular death, and hyperkalaemia. Heterogeneity was assessed using I2. Results: Across a network comprising 10 644 patients, mean age 70.2; 48% women; mean LVEF 54.9%, finerenone reduced hospitalization for HF vs placebo (RR 0.84; 95% CrI 0.75–0.93), whereas spironolactone (RR 0.86; 95% CrI 0.73–1.01) and eplerenone (RR 0.86; 95% CrI 0.59–1.26) showed non-significant effects. None of the MRAs achieved a statistically significant reduction in cardiovascular mortality vs placebo: finerenone (RR 0.93; 95% CrI 0.78–1.10), spironolactone (RR 0.93; 95% CrI 0.76–1.14), and eplerenone (RR 1.10; 95% CrI 0.29–5.69). All MRAs increased hyperkalaemia vs placebo: finerenone (RR 2.06; 95% CrI 1.77–2.41), spironolactone (RR 2.13; 95% CrI 1.81–2.53), and eplerenone (RR 2.17; 95% CrI 0.75–7.97). Conclusion: In HFpEF/HFmrEF, finerenone was the only MRA to significantly reduce hospitalization for HF, while no agent significantly reduced cardiovascular mortality and hyperkalaemia risk increased across therapies. Overall, finerenone may offer the most favourable efficacy–safety balance among MRAs, pending confirmation in larger dedicated trials.
- Open Access
- 1 July 2025
- Published by BMJ in Open Heart
- Vol. 12 (2) , e003762
Use of beta-blockers and in-hospital mortality in patients with Takotsubo cardiomyopathy: systematic review and meta-analysis
Introduction: Takotsubo cardiomyopathy (TC) is a stress-induced catecholamine acute myocardial dysfunction in the absence of significant coronary disease. The pathophysiology of TC remains poorly understood, and the use of beta-blockers (β-Blockers) appears promising. However, the impact of β-blockers in acute-phase management remains uncertain. Aims: We aimed to conduct a systematic review and meta-analysis evaluating the early use of β-Blocker in TC and its effects on in-hospital mortality. Methods: PubMed, Embase and Cochrane were searched for studies that evaluated the use of BBs in TC patients and its short-term effects. Statistical analysis was performed using RevMan V,5.4.1. The results are expressed using HRs and 95% confidence intervals (CI) were extracted using a random-effects model. Heterogeneity was assessed with I². Results: We included five cohort studies, with a total of 5428 patients. The vast majority were women (81%) with a mean age of 70.1±12.6 years. More than half of the patients (52.0%) had previous hypertension. ST-elevation in the first ECG was observed in 37.3% of the patients. Early administration of β-blockers was not associated with a statistically significant reduction in in-hospital mortality (HR 0.78, 95% CI 0.59 to 1.02, p=0.07), and this finding was consistent across different β-blocker types, doses and routes of administration. Conclusion: Early β-Blocker therapy did not significantly influence in-hospital mortality in patients with TC. Future randomised studies are essential to clarify beta-blockers’ role in this setting. PROSPERO registration number: CRD420251055617.
- 1 July 2025
- Published by BMJ in Open Heart
- Vol. 12 (2) , e003762
Open AccessUse of beta-blockers and in-hospital mortality in patients with Takotsubo cardiomyopathy: systematic review and meta-analysis
Introduction: Takotsubo cardiomyopathy (TC) is a stress-induced catecholamine acute myocardial dysfunction in the absence of significant coronary disease. The pathophysiology of TC remains poorly understood, and the use of beta-blockers (β-Blockers) appears promising. However, the impact of β-blockers in acute-phase management remains uncertain. Aims: We aimed to conduct a systematic review and meta-analysis evaluating the early use of β-Blocker in TC and its effects on in-hospital mortality. Methods: PubMed, Embase and Cochrane were searched for studies that evaluated the use of BBs in TC patients and its short-term effects. Statistical analysis was performed using RevMan V,5.4.1. The results are expressed using HRs and 95% confidence intervals (CI) were extracted using a random-effects model. Heterogeneity was assessed with I². Results: We included five cohort studies, with a total of 5428 patients. The vast majority were women (81%) with a mean age of 70.1±12.6 years. More than half of the patients (52.0%) had previous hypertension. ST-elevation in the first ECG was observed in 37.3% of the patients. Early administration of β-blockers was not associated with a statistically significant reduction in in-hospital mortality (HR 0.78, 95% CI 0.59 to 1.02, p=0.07), and this finding was consistent across different β-blocker types, doses and routes of administration. Conclusion: Early β-Blocker therapy did not significantly influence in-hospital mortality in patients with TC. Future randomised studies are essential to clarify beta-blockers’ role in this setting. PROSPERO registration number: CRD420251055617.
- Open Access
- 31 December 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 3 (4)
Evolution of Hematological Parameters in Patients with Vasoplegia Following Coronary Artery Bypass Graft Surgery
Background: The utilization of extracorporeal circulation during a coronary artery bypass graft (CABG) surgery induces the secretion of inflammatory mediators associated with the onset of vasoplegic syndrome (VS). Blood cells contribute to the amplification of enzymatic mechanisms related to the development of VS, which is responsible for high mortality rates. Objectives: To investigate possible changes in hematological ratios to evaluate the evolution of VS in patients undergoing CABG. Methods: Analytical observational study of the retrospective cohort type, utilizing data [...] Abstract Background: The utilization of extracorporeal circulation during a coronary artery bypass graft (CABG) surgery induces the secretion of inflammatory mediators associated with the onset of vasoplegic syndrome (VS). Blood cells contribute to the amplification of enzymatic mechanisms related to the development of VS, which is responsible for high mortality rates. Objectives: To investigate possible changes in hematological ratios to evaluate the evolution of VS in patients undergoing CABG. Methods: Analytical observational study of the retrospective cohort type, utilizing data
- 31 December 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 3 (4)
Open AccessEvolution of Hematological Parameters in Patients with Vasoplegia Following Coronary Artery Bypass Graft Surgery
Background: The utilization of extracorporeal circulation during a coronary artery bypass graft (CABG) surgery induces the secretion of inflammatory mediators associated with the onset of vasoplegic syndrome (VS). Blood cells contribute to the amplification of enzymatic mechanisms related to the development of VS, which is responsible for high mortality rates. Objectives: To investigate possible changes in hematological ratios to evaluate the evolution of VS in patients undergoing CABG. Methods: Analytical observational study of the retrospective cohort type, utilizing data [...] Abstract Background: The utilization of extracorporeal circulation during a coronary artery bypass graft (CABG) surgery induces the secretion of inflammatory mediators associated with the onset of vasoplegic syndrome (VS). Blood cells contribute to the amplification of enzymatic mechanisms related to the development of VS, which is responsible for high mortality rates. Objectives: To investigate possible changes in hematological ratios to evaluate the evolution of VS in patients undergoing CABG. Methods: Analytical observational study of the retrospective cohort type, utilizing data
- Open Access
- 18 December 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 36 (4)
Uso Direcionado da Ecocardiografia Como Ferramenta de Auxílio no Ensino da Anatomia e da Fisiologia Cardíacas para Estudantes de Medicina
Fundamento: A ultrassonografia vem sendo cada vez mais utilizada para o ensino da medicina básica. A observação simultânea da imagem ecocardiográfica e do eletrocardiograma (ECG) permite que o estudante compreenda o processo fisiológico do coração e sua função dentro do sistema cardiovascular. Objetivo: Avaliar o ganho e a retenção de conhecimento do estudante de medicina no aprendizado da anatomia e da fisiologia cardíacas com uso da ecocardiografia. Métodos: Trinta e quatro estudantes do terceiro semestre realizaram um pré-teste (avaliação 1) composto por 20 questões de múltipla escolha, sendo 15 relacionadas à anatomia e fisiologia cardíacas e 5 “questões de confusão”. O teste foi elaborado por um dos autores, sendo de forma cega para os demais. Após o encontro teórico, foi efetuada a avaliação 2 com as mesmas questões. Na semana seguinte, foi realizado o encontro prático de ecocardiografia direcionado para avaliação da anatomia e fisiologia. Um pós-teste (avaliação 3) foi realizado 30 dias após o primeiro encontro para avaliar a retenção do conhecimento. As variáveis foram analisadas pelos testes Kolmogorov-Smirnov, T de Student e Wilcoxon, com nível de significância estatística representando um valor de p < 0,05. Resultados: A média de acertos na avaliação 1 foi de 6,37 ± 2,0 (42,4%), na segunda avaliação de 9,8 ± 2,2 (65,3%) e na avaliação 3 de 10,3 ± 2,5 (68,6%). Houve diferença estatística entre a avaliação 1 e as demais avaliações (p = 0,01). Conclusão: O uso da ecocardiografia de maneira precoce dentro do curso de medicina auxilia de forma positiva o ensino da fisiologia e anatomia cardíacas, fixando o conhecimento teórico adquirido.
- 18 December 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 36 (4)
Open AccessUso Direcionado da Ecocardiografia Como Ferramenta de Auxílio no Ensino da Anatomia e da Fisiologia Cardíacas para Estudantes de Medicina
Fundamento: A ultrassonografia vem sendo cada vez mais utilizada para o ensino da medicina básica. A observação simultânea da imagem ecocardiográfica e do eletrocardiograma (ECG) permite que o estudante compreenda o processo fisiológico do coração e sua função dentro do sistema cardiovascular. Objetivo: Avaliar o ganho e a retenção de conhecimento do estudante de medicina no aprendizado da anatomia e da fisiologia cardíacas com uso da ecocardiografia. Métodos: Trinta e quatro estudantes do terceiro semestre realizaram um pré-teste (avaliação 1) composto por 20 questões de múltipla escolha, sendo 15 relacionadas à anatomia e fisiologia cardíacas e 5 “questões de confusão”. O teste foi elaborado por um dos autores, sendo de forma cega para os demais. Após o encontro teórico, foi efetuada a avaliação 2 com as mesmas questões. Na semana seguinte, foi realizado o encontro prático de ecocardiografia direcionado para avaliação da anatomia e fisiologia. Um pós-teste (avaliação 3) foi realizado 30 dias após o primeiro encontro para avaliar a retenção do conhecimento. As variáveis foram analisadas pelos testes Kolmogorov-Smirnov, T de Student e Wilcoxon, com nível de significância estatística representando um valor de p < 0,05. Resultados: A média de acertos na avaliação 1 foi de 6,37 ± 2,0 (42,4%), na segunda avaliação de 9,8 ± 2,2 (65,3%) e na avaliação 3 de 10,3 ± 2,5 (68,6%). Houve diferença estatística entre a avaliação 1 e as demais avaliações (p = 0,01). Conclusão: O uso da ecocardiografia de maneira precoce dentro do curso de medicina auxilia de forma positiva o ensino da fisiologia e anatomia cardíacas, fixando o conhecimento teórico adquirido.
- Open Access
- 18 December 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 36 (4)
Use of Echocardiography as a Supplementary Tool in Teaching Cardiac Anatomy and Physiology to Medical Students
Background: Ultrasonography has been increasingly used in teaching basic medicine. The simultaneous observation of the echocardiographic image
- 18 December 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Imagem Cardiovascular
- Vol. 36 (4)
Open AccessUse of Echocardiography as a Supplementary Tool in Teaching Cardiac Anatomy and Physiology to Medical Students
Background: Ultrasonography has been increasingly used in teaching basic medicine. The simultaneous observation of the echocardiographic image
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (5) , e20220917
Analysis of possible risk predictors in patients with coronavirus disease 2019: a retrospective cohort study
This study aimed to analyze the clinical-epidemiological profile, possible risk predictors, and outcomes of patients with coronavirus disease 2019 admitted to the ward of a tertiary care hospital in southern Brazil. Specifically, we describe the demographic characteristics, comorbidities, baseline laboratory findings, clinical course, and survival of these patients.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 69 (5) , e20220917
Open AccessAnalysis of possible risk predictors in patients with coronavirus disease 2019: a retrospective cohort study
This study aimed to analyze the clinical-epidemiological profile, possible risk predictors, and outcomes of patients with coronavirus disease 2019 admitted to the ward of a tertiary care hospital in southern Brazil. Specifically, we describe the demographic characteristics, comorbidities, baseline laboratory findings, clinical course, and survival of these patients.